|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Homogalacturonan MethyI-Esterification and Plant Development显示文摘 | Sebastian Wolf Gregory Mouille Jerome Pelloux | 2009 | Molecular Plant2009,2,5: | 20 |
| 2 | 动脉瘤性蛛网膜下腔出血患者的重症监护处理:神经危重症监护学会多学科共识会议的推荐意见显示文摘蛛网膜下腔出血(subarachnoidhemorrhage,SAH)是一种可对中枢神经系统造成毁灭性打击并对其他多个器官产生显著影响的急性脑血管病。SAH患者被常规收入重症监护病房并由多学科团队进行治疗。由于高质量研究证据的缺乏,使得治疗方法各异,可供选择的指导意见不多。现有的指南主要强调危险因素、预防、自然史以及再出血的预防,很少涉及SAH患者的重症监护问题。美国神经危重症监护学会组织了一次国际性多学科共识会议来探讨SAH的重症监护处理。根据发表的文章和研究领域,此次会议召集了来自欧洲和北美地区的神经重症监护科、神经外科、神经内科、介入神经放射科和神经麻醉科方面的专家。根据临床经验和制定实践指南方面的经验,选择4名经验丰富的神经重症监护专家组成评判委员会。应用推荐分级的评估、制定与评价(GradesofRecommendationsAssessment,DevelopmentandEvaluation,GRADE)系统进行文献回顾,结合参会者的经验、评判委员会的审评以及文献讨论产生推荐意见。应用GRADE系统制定推荐意见,其制定原则不仅强调研究资料的质量,而且还重视利弊权衡与实践转化。对SAH患者日常处理过程中面临的所有问题均提供指导和推荐意见,即使缺乏高质量的证据。 | Michael N. Diringer Thomas P. Bleck J. Claude Hemphill David Menon Lori Shutter Paul Vespa Nicolas Bruder E. Sander Connolly Jr Giuseppe Citerio Daryl Gress Daniel Hanggi Brian L. Hoh Giuseppe Lanzino Peter Le Roux Alejandro Rabinstein, Erich Schmut zhard Nino Stocchetti Jose I. Suarez Miriam Tresgiari Ming-Yuan Tseng Mervyn D. I. Vergouwen Stefan Wolf Gregory Zip fel 田飞(译) 宿 英英(译) | 2013 | 国际脑血管病杂志2013,21,5: | 5 |
| 3 | Symptom management during and after treatment with concurrent chemoradiotherapy for oropharyngeal cancer:A review of the literature and areas for future research显示文摘Patients with locally advanced oropharyngeal cancer are at risk for poor outcomes due to the multi-modal nature of treatment and the potential for treatmentrelated toxicity.Although treatment with concurrent chemotherapy and radiotherapy has drastically reduced the need for a debilitating and disfiguring surgery,treatment related toxicities are often difficult to control.Acute toxicities include mucositis,skin desquamation,depression,cachexia,fatigue and nausea and vomiting.Failure to control these symptoms can adversely affect the patient's ability to complete their treatment regimen.Although there are many promising new treatments in the area of symptom management for this patient population,a review of the literature reflects the need for more research. | Heidi Mason Mary Beth De Rubeis Nancy Burke Melissa Shannon Danielle Karsies Gregory Wolf Avi Eisbruch Francis Worden | 2016 | World Journal of Clinical Oncology2016,7,2: | 5 |
| 4 | Do clusters make a difference? defining and assessing their economic performance显示文摘 | SPENCER GREGORY TARA VINODRAI MERIC GERTLER WOLFE D | 2010 | Regional Studies2010,44,6: | 1 |
| 5 | Primary Prevention of Ischemic Stroke: A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association显示文摘 | Larry B. Goldstein Robert Adams Kyra Becker Curt D. Furberg Philip B. Gorelick George Hademenos Martha Hill George Howard Virginia J. Howard Bradley Jacobs Steven R. Levine Lori Mosca Ralph L. Sacco David G. Sherman Philip A. Wolf Gregory J. del Zoppo | 2001 | Stroke: Journal of the American Heart Association2001,,1: | 1 |
| 6 | Early decompressive craniectomy for patients with severe traumatic brain injury and refractory intracranial hypertension—A pilot randomized trial显示文摘 | D. James Cooper Jeffrey V. Rosenfeld Lynnette Murray Rory Wolfe Jennie Ponsford Andrew Davies Paul D’Urso Vincent Pellegrino Gregory Malham Thomas Kossmann | 2008 | Journal of Critical Care2008,,3: | 1 |
| 7 | Cervical Spine Magnetic Resonance Imaging in Alert, Neurologically Intact Trauma Patients With Persistent Midline Tenderness and Negative Computed Tomography Results显示文摘 | Helen M. Ackland Peter A. Cameron Dinesh K. Varma Gregory J. Fitt D. James Cooper Rory Wolfe Gregory M. Malham Jeffrey V. Rosenfeld Owen D. Williamson Susan M. Liew | 2011 | Annals of Emergency Medicine2011,,6: | 1 |
| 8 | Reversibility of PRKAG2 Glycogen-Storage Cardiomyopathy and Electrophysiological Manifestations显示文摘 | Cordula M. Wolf Michael Arad Ferhaan Ahmad Atsushi Sanbe Scott A. Bernstein Okan Toka Tetsuo Konno Gregory Morley Jeffrey Robbins J G. Seidman Christine E. Seidman Charles I. Berul | 2008 | Circulation2008,,2: | 1 |
| 9 | Tracing the fate and recycling of 13C-labeled glucose in soil 显示文摘 | SUSAN E ZIEGLER PAUL M WHITE DUANE C WOLF and GREGORY J THOMA | 2005 | Soil Science2005,170,: | 1 |
| 10 | Primary Prevention of Ischemic Stroke: A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association显示文摘 | Larry B. Goldstein Robert Adams Kyra Becker Curt D. Furberg Philip B. Gorelick George Hademenos Martha Hill George Howard Virginia J. Howard Bradley Jacobs Steven R. Levine Lori Mosca Ralph L. Sacco David G. Sherman Philip A. Wolf Gregory J. del Zoppo | 2001 | Stroke: Journal of the American Heart Association2001,,1: | 1 |
| 11 | Trends and outcomes of liver transplantation among older recipients in the United States显示文摘BACKGROUND The average age of recipients and donors of liver transplantation(LT)is increasing.Although there has been a change in the indications for LT over the years,data regarding the trends and outcomes of LT in the older population is limited.AIM To assess the clinical characteristics,age-related trends,and outcomes of LT among the older population in the United States.METHODS We analyzed data from the United Network for Organ Sharing database between 1987-2019.The sample was split into younger group(18-64 years old)and older group(≥65 years old).RESULTS Between 1987-2019,155758 LT were performed in the United States.During this period there was a rise in median age of the recipients and percentage of LT recipients who were older than 65 years increased(P<0.05)with the highest incidence of LT among older population seen in 2019(1920,23%).Common primary etiologies of liver disease leading to LT in older patients when compared to the younger group,were non-alcoholic steatohepatitis(16.4%vs 5.9%),hepatocellular carcinoma(14.9%vs 6.9%),acute liver failure(2.5%vs 5.2%),hepatitis C cirrhosis(HCV)(19.2%vs 25.6%)and acute alcoholic hepatitis(0.13%vs 0.35%).In older recipient group female sex and Asian race were higher,while model for end-stage liver disease(MELD)score and rates of preoperative mechanical ventilation were lower(P<0.01).Median age of donor,female sex,body mass index(BMI),donor HCV positive status,and donor risk index(DRI)were significantly higher in older group(P<0.01).In univariable analysis,there was no difference in post-transplant length of hospitalization,one-year,three-year and five-year graft survivals between the two groups.In multivariable Cox-Hazard regression analysis,older group had an increased risk of graft failure during the five-year post-transplant period(hazard ratio:1.27,P<0.001).Other risk factors for graft failure among recipients were male sex,African American race,re-transplantation,presence of diabetes,mechanical ventilation at the time of LT,higher MELD score,presence of portal vein thrombosis,HCV positive status,and higher DRI.CONCLUSION While there is a higher risk of graft failure in older recipient population,age alone should not be a contraindication for LT.Careful selection of donors and recipients along with optimal management of risk factors during the postoperative period are necessary to maximize the transplant outcomes in this population. | Kenji Okumura Joon Sub Lee Abhay Dhand Hiroshi Sogawa Gregory Veillette Devon John Ryosuke Misawa Roxana Bodin David C Wolf Thomas Diflo Seigo Nishida | 2022 | World Journal of Transplantation2022,12,8: | 0 |